Abstract
A 57-year-old female with recurrent AML underwent a T cell-depleted (TCD) bone marrow (BM) plus TCD and CD34-selected peripheral blood stem cell (PBSC) transplant. Eleven weeks post transplantation, the patient developed acute graft-versus-host disease (GVHD) manifested by rash and elevated liver enzymes. Concurrently, the patient presented with a bleeding diathesis and a left forearm hematoma due to the development of a spontaneous factor VIII inhibitor. She was treated with human recombinant factor VIII and intravenous methylprednisolone. Subsequently she was managed with a prednisone taper leading to resolution of the GVHD, as well as the spontaneous factor VIII inhibitor. Bone marrow transplant-related spontaneous factor VIII inhibitor has previously been reported in association with one patient with chronic GVHD. To our knowledge this is the first report of spontaneous factor VIII inhibitor associated with acute GVHD. Bone Marrow Transplantation (2001) 27, 887–889.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ferrara JLM, Deeg HJ . Graft-versus-host disease New Engl J Med 1991 324: 667–674
O'Reilly RJ, Papadopoulos EB . Allogeneic transplantation In: Holland JF et al (eds) Cancer Medicine 4th edn: Lea-Febiger: Philadelphia 1997 pp 1295–1324
Biggs R . Human Blood Coagulation, Hemostasis and Thrombosis Blackwell Scientific Publications: Oxford 1972
Morrison AE, Ludlam CA . Acquired haemophilia and its management Br J Haematol 1995 89: 231–236
Lusher JM . Factor VIII inhibitors: etiology, characterization, natural history, and management Ann NY Acad Sci 1987 509: 89–102
White GC, McMillan CW, Blatt PM, Roberts HR . Factor VIII inhibitors: a clinical overview Am J Hematol 1982 13: 335–342
Sohngen D, Specker C, Bach D et al. Acquired factor VIII inhibitors in nonhemophilic patients Ann Hematol 1997 74: 89–93
Green D, Lechner K . A survey of 215 non-hemophilic patients with inhibitors to factor VIII Thromb Haemostas 1981 45: 200–203
Seidler CW, Mills LE, Flowers MED, Sullivan KM . Spontaneous factor VIII occurring in association with chronic graft-versus-host disease Am J Hematol 1994 45: 240–243
Greeno EW, Haake R, McGlave P et al. Lupus inhibitors following bone marrow transplant Bone Marrow Transplant 1995 15: 287–291
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brentjens, R., Smith, L., Reich, L. et al. Development of spontaneous factor VIII inhibitor in association with acute graft-versus-host disease. Bone Marrow Transplant 27, 887–889 (2001). https://doi.org/10.1038/sj.bmt.1703009
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703009
Keywords
This article is cited by
-
Rituximab as a treatment for factor VIII inhibitor in a patient with chronic GVHD
Bone Marrow Transplantation (2014)